Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Sell
32
ATNM Quote, Financials, Valuation and Earnings
Last price:
$1.64
Seasonality move
:
-1.85%
Day range:
$1.50 - $1.61
52-week range:
$1.03 - $8.64
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
1.93x
Volume:
165.9K
Avg. volume:
410.8K
1-year change:
-79.51%
Market cap:
$49.6M
Revenue:
$81K
EPS (TTM):
-$1.47
Earnings Data
Next earnings date for ATNM
Aug 05
2025
Most recent earnings per share
-$0.51
Missed by $0.23
(May 9/2025)
Consensus Estimate
-$0.28
(May 9/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
ATNM Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 09/30/2025 | Q3 | -- | -- | -- | -$0.36 | -- |
| 08/05/2025 | Q2 | -- | -- | -- | -$0.35 | -- |
| 05/09/2025 | Q1 | -- | -- | -$0.51 | -$0.28 | -$0.23 |
| 12/31/2024 | Q4 | -- | -- | -$0.21 | -$0.39 | $0.18 |
| 11/14/2024 | Q3 | -- | -- | -$0.37 | -$0.37 | -$0.00 |
| 08/05/2024 | Q2 | -- | -- | -$0.38 | -$0.40 | $0.02 |
| 04/26/2024 | Q1 | -- | -- | -$0.31 | -$0.52 | $0.21 |
| 12/31/2023 | Q4 | -- | $81K | -$0.33 | -$0.54 | $0.21 |
| 11/02/2023 | Q3 | $460K | -- | -$0.49 | -$0.57 | $0.08 |
| 08/14/2023 | Q2 | -- | -- | -$0.58 | -$0.49 | -$0.09 |
| 05/15/2023 | Q1 | -- | -- | -$0.43 | -- | -- |
| 12/31/2022 | Q4 | -- | -- | -$0.43 | -- | -- |
| 11/14/2022 | Q3 | -- | $45K | -$0.38 | -- | -- |
| 08/12/2022 | Q2 | -- | $45K | -$0.33 | -- | -- |
| 05/13/2022 | Q1 | -- | $940K | -$0.23 | -- | -- |
| 02/24/2022 | Q4 | -- | $23K | -$0.36 | -- | -- |
| 11/12/2021 | Q3 | -- | $233K | -$0.30 | -- | -- |
| 07/30/2021 | Q2 | -- | $266K | -$0.25 | -- | -- |
| 05/14/2021 | Q1 | -- | $622K | -$0.29 | -- | -- |
| 12/31/2020 | Q4 | -- | -- | -$0.37 | -- | -- |
| 10/23/2020 | Q3 | -- | -- | -$0.36 | -- | -- |
| 06/30/2020 | Q2 | -- | -- | -$0.41 | -- | -- |
| 05/08/2020 | Q1 | -- | -- | -$0.98 | -- | -- |
| 03/19/2020 | Q4 | -- | -- | -$0.80 | -- | -- |
| 10/28/2019 | Q3 | -- | -- | -$1.21 | -- | -- |
| 08/09/2019 | Q2 | -- | -- | -$1.00 | -- | -- |
| 03/31/2019 | Q1 | -- | -- | -$1.50 | -- | -- |
| 03/19/2019 | Q4 | -- | -- | -$1.50 | -- | -- |
| 11/09/2018 | Q3 | -- | -- | -$1.80 | -- | -- |
| 08/09/2018 | Q2 | -- | -- | -$1.20 | -- | -- |
| 03/31/2018 | Q1 | -- | -- | -$2.10 | -- | -- |
| 12/31/2017 | Q4 | -- | -- | -$1.80 | -- | -- |
| 11/03/2017 | Q3 | -- | -- | -$2.70 | -- | -- |
| 08/04/2017 | Q2 | -- | -- | -$3.60 | -- | -- |
| 03/31/2017 | Q1 | -- | -- | -$4.20 | -- | -- |
| 03/17/2017 | Q4 | -- | -- | -$3.60 | -- | -- |
| 10/28/2016 | Q3 | -- | -- | -$4.20 | -- | -- |
| 07/29/2016 | Q2 | -- | -- | -$4.20 | -- | -- |
| 05/13/2016 | Q1 | -- | -- | -$3.00 | -- | -- |
| 04/04/2016 | Q4 | -- | -- | -$4.80 | -- | -- |
| 11/27/2015 | Q3 | -- | -- | -$3.00 | -- | -- |
Actinium Pharmaceuticals Earnings Questions
-
How Much did Actinium Pharmaceuticals Generate in Revenue Last Quarter?
Actinium Pharmaceuticals reported -- worth of top line sales in its most recent quarter.
-
Did Actinium Pharmaceuticals Beat Earnings Last Quarter?
Actinium Pharmaceuticals announced earnings per share of -$0.51 which represents a miss of analyst forecast a -$0.28 per share.
-
Is Actinium Pharmaceuticals Profitable?
Actinium Pharmaceuticals reported -- that represents -- per share over the last quarter.
-
What is the Analyst Consensus for Actinium Pharmaceuticals EPS Next Year?
Actinium Pharmaceuticals's earnings are forecast to decrease from -$1.27 per share to -$1.43 per share next year representing a decrease of -16.54%.
-
When is Actinium Pharmaceuticals's Earnings Date?
Actinium Pharmaceuticals's next earnings date is August 5, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
70
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 58x
Buy
62
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
82
SBET alert for Jul 17
SharpLink Gaming [SBET] is down 2.6% over the past day.
Buy
89
EXOD alert for Jul 17
Exodus Movement [EXOD] is down 4.14% over the past day.
Buy
60
U alert for Jul 17
Unity Software [U] is up 7.51% over the past day.
